|
VCFS
MCID: VLC001
|
Velocardiofacial Syndrome malady |
|
Sources: 30NIH Rare Diseases, 17Genetics Home Reference, 44Wikipedia, 33OMIM, 15GeneReviews, 22MalaCards See all sources Export this MalaCard |
NIH Rare Diseases: 22q11.2 deletion syndrome is a spectrum disorder encompassing what was formerly called DiGeorge syndrome, velocardiofacial syndrome, conotruncal anomaly face syndrome, and cases of Opitz G/BBB syndrome, and Cayler cardiofacial syndrome. It is characterized by a variety of symptoms, including cleft palate, heart defects, unique facial characteristics, learning and feeding problems, immune system disorders, hypoparathyroidism, and scoliosis. Symptoms can vary greatly from patient to patient. It is caused by a missing piece (deletion) of chromosome 22. The deletion occurs near the middle of the chromosome at a location designated q11.2. Click here to view a diagram of chromosome 22.30
MalaCards: Velocardiofacial Syndrome, also known as shprintzen syndrome, is related to schizophrenia and conotruncal anomaly face syndrome. An important gene associated with Velocardiofacial Syndrome is GP1BB (glycoprotein Ib (platelet), beta polypeptide), and among its related pathways is Platelet Aggregation (Plug Formation). The compounds ristocetin and L-Lysine have been mentioned in the context of this disorder. Affiliated tissues include brain, heart and myeloid. Genetics Home Reference: 22q11.2 deletion syndrome is a disorder caused by the deletion of a small piece of chromosome 22. The deletion occurs near the middle of the chromosome at a location designated q11.2.17 Wikipedia: 22q11.2 deletion syndrome, which has several presentations including DiGeorge syndrome (DGS), DiGeorge...44 more... OMIM: 192430 GeneReviews summary for gr_22q11deletion |
|
Sources: 6Disease Ontology, 7diseasecard, 44Wikipedia, 15GeneReviews, 30NIH Rare Diseases, 16GeneTests, 17Genetics Home Reference, 8DISEASES, 33OMIM, 32Novoseek , 43UMLS, 24MeSH, 19ICD9CM, 40SNOMED-CT See all sources |
Aliases & Descriptions:
|
|
Sources: 33OMIM See all sources |
Clinical features from OMIM: 192430
|
|
Sources: 4CenterWatch, 29NIH Clinical Center, 5ClinicalTrials, 43UMLS, 28NDF-RT See all sources |
Approved drugs:Search CenterWatch for velocardiofacial syndrome Drug clinical trials:Search ClinicalTrials for velocardiofacial syndrome Search NIH Clinical Center for velocardiofacial syndrome Search CenterWatch for velocardiofacial syndrome |
|
Sources: 16GeneTests See all sources |
|
Sources: 22MalaCards See all sources |
MalaCards organs/tissues related to velocardiofacial syndrome:22Brain, Heart, Myeloid, T cells
|
|
|
|
Sources: 35PubMed See all sources |
Articles related to velocardiofacial syndrome:(show all 15)
|
|
Sources: 1BioGPS See all sources |
![]() |
|
Sources: 38Reactome See all sources |
Pathways related to velocardiofacial syndrome according to GeneDecks:
|
|
Sources: 32Novoseek , 9DrugBank, 18HMDB See all sources |
|
Sources: 12Gene Ontology See all sources |
Biological processes related to velocardiofacial syndrome according to GeneDecks:
Molecular functions related to velocardiofacial syndrome according to GeneDecks:
|
